PeptidePedia The community reference

Contributions of UnitsUrsula

User contributions·42 logged edits·page 1 of 1

Contributions by UnitsUrsula, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 16,092 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Asymchem Laboratories 17,160 ±0 m label the reception tally as weak, self-selected evidence at this point of use
  2. 18:36, 18 Jul 2026 (diff | hist) Sharps disposal 20,876 ±0 de-orphan
  3. 16:05, 17 Jun 2026 (diff | hist) Semaglutide 10,355 ±0 m add the excipient list from the labelling
  4. 06:27, 3 Jun 2026 (diff | hist) PolyPeptide Group (Hangzhou) 18,363 ±0 m typo
  5. 09:01, 13 May 2026 (diff | hist) Talk:Syringe dead space 1,233 +198 /* Should this article carry the vial-yield table, or should the calculator? */ reply
  6. 12:06, 25 Apr 2026 (diff | hist) Good manufacturing practice 5,123 ±0 convert the jurisdiction comparison to a table
  7. 14:38, 15 Mar 2026 (diff | hist) FLOW trial 4,583 ±0 add the confidence interval to the point estimate
  8. 10:56, 8 Mar 2026 (diff | hist) Repackaging 4,759 ±0 m state the residual-moisture target with the method it is measured by
  9. 22:54, 17 Feb 2026 (diff | hist) GLP-1 receptor 7,570 ±0 the article treated a rodent finding as human physiology; corrected
  10. 13:25, 31 Jan 2026 (diff | hist) Talk:Insulin syringe 611 +121 /* Table is arithmetic, not guidance */ reply
  11. 13:05, 13 Jan 2026 (diff | hist) Talk:Reconstitution of lyophilised peptides 611 +106 /* Nominal versus actual concentration */ reply
  12. 05:38, 13 Jan 2026 (diff | hist) Incretin effect 7,358 ±0 unpipe a link that did not need piping
  13. 21:59, 10 Jan 2026 (diff | hist) Sarcopenia 4,491 ±0 correct the decimal place in the conversion factor
  14. 15:28, 9 Jan 2026 (diff | hist) Talk:Insulin syringe unit conversion 611 +401 /* Is the U-40 material needed at all? */ reply
  15. 21:40, 7 Jan 2026 (diff | hist) Janoshik Analytical 5,235 ±0 fix a dangling clause
  16. 10:07, 23 Dec 2025 (diff | hist) SURPASS trial programme 5,078 ±0 m give the primary endpoint as pre-specified, not as reported
  17. 09:48, 18 Dec 2025 (diff | hist) SinoPep 15,567 +2,128 clarify that a registered business scope is a licensing fact, not a quality assurance
  18. 22:42, 11 Dec 2025 (diff | hist) Flourishglobal Peptide Biotech 13,174 +798 state what the certificate supplied with orders carries
  19. 11:58, 7 Dec 2025 (diff | hist) Guangzhou JEEP Biotechnology 15,232 ±0 m add the note that self-published material is usable only for what it states about itself
  20. 23:45, 4 Dec 2025 (diff | hist) Bacteriostatic water 4,652 ±0 m correct the label on the second column — that is volume, not mass
  21. 11:53, 4 Dec 2025 (diff | hist) Subcutaneous injection 5,293 ±0 clarify which volume the graduation marks measure
  22. 12:40, 3 Nov 2025 (diff | hist) Talk:Syringe dead space 611 +239 /* The 35% figure is being cited elsewhere as an unconditional dose error */ reply
  23. 22:42, 31 Oct 2025 (diff | hist) Custom peptide synthesis 4,773 ±0 m convert the storage conditions to a table
  24. 01:00, 29 Oct 2025 (diff | hist) Beyond-use date 21,662 +497 copyedit
  25. 07:40, 27 Oct 2025 (diff | hist) Shanghai ERP Biotechnology 8,349 +381 rm the discount code added by an anonymous editor
  26. 17:39, 25 Oct 2025 (diff | hist) Baseline laboratory panel 4,429 ±0 correct the analyte name to the recommended nomenclature
  27. 09:55, 22 Aug 2025 (diff | hist) Talk:Reconstitution calculator 1,096 +118 /* Dead space: delivered dose or vial yield? */ reply
  28. 12:50, 7 May 2025 (diff | hist) C-peptide 4,233 +775 convert the interval table to include both conventional and SI units
  29. 18:28, 1 Apr 2025 (diff | hist) LEADER trial 3,537 ±0 m split the results table so the two doses are separate rows
  30. 01:12, 23 Mar 2025 (diff | hist) Glucagon 5,754 ±0 state which salt form the mass in the infobox refers to
  31. 23:09, 11 Mar 2025 (diff | hist) Qingdao Sigma Chemical 9,233 +392 expand §Distribution and dispatch
  32. 00:32, 1 Mar 2025 (diff | hist) Subcutaneous injection 4,039 ±0 ce
  33. 09:47, 16 Feb 2025 (diff | hist) Preparative HPLC purification 3,866 ±0 add the collapse-temperature point, sourced
  34. 11:18, 29 Nov 2024 (diff | hist) Area percent purity 3,599 ±0 add the cross-link to the compendial chapter
  35. 12:19, 10 Nov 2024 (diff | hist) List of GLP-1 receptor agonists 2,606 +349 sort the list by the column the lead says it is sorted by
  36. 02:45, 7 Nov 2024 (diff | hist) USP General Chapter 85 2,086 ±0 state the column chemistry and the gradient the figure was obtained on
  37. 06:14, 3 Nov 2024 (diff | hist) Amylin 3,204 ±0 give the strength per pen as well as per millilitre
  38. 14:52, 5 Oct 2024 (diff | hist) Talk:Reconstitution calculator 1,033 +195 /* Does this page cross the line into instruction? */ reply
  39. 08:42, 15 Sep 2024 (diff | hist) Bacteriostatic water 2,807 ±0 state the assumption that the whole vial is reconstituted at once
  40. 09:00, 14 Sep 2024 (diff | hist) Fasting insulin 1,061 +1,061 N start article; reference intervals to follow
  41. 23:39, 18 Aug 2024 (diff | hist) GL Biochem (Shanghai) 5,325 +1,045 expand §Regulatory position and legal status
  42. 09:22, 13 Aug 2024 (diff | hist) Talk:Cold chain 822 +256 /* Storage definitions: table or prose? */ reply